The risk for neonatal sepsis in the GBS subgroup was significantly higher after EM (1.8% after IoL vs. 15.2% after EM, OR 0.10, 95% CI 0.01-0.84); therefore, in the PPROMEXIL-trials IoL was strongly advised (Tajik et al. 2014 I BJOG i ;121:1263-72). A number of randomised trials have evaluated induction of labour (IoL) versus expectant management (EM) for late preterm prelabour rupture of membranes (PPROM) occurring between 34 and 37 weeks of gestation, including the PPROMEXIL-trials (van der Ham et al. 2012 I PLoS Med i ;9:e1001208; van der Ham et al. I Am J Obstet Gynecol i 2012;207:276.e1-10) and the PPROMT trial (Morris et al. I Lancet i 2016;387:444-52). Therefore, given the morbidity of neonatal sepsis and the data showing increased neonatal sepsis rates in patients testing positive for GBS, immediate delivery should be considered. [Extracted from the article]